Lucknow bribery case: CBI arrests two narcotics inspectors, nursing home owner

Lucknow: In a major operation against corruption in drug enforcement, the Central Bureau of Investigation (CBI) has apprehended two Inspectors of the Central Bureau of Narcotics (CBN), Lucknow – Mahipal Singh and Ravi Ranjan – along with Gayasuddin Ahmad, the owner of a private nursing home in Luckow, for allegedly being involved in a Rs 10 lakh bribery scandal.

The case was registered by the CBI on August 26, 2025, following credible information from a reliable source that the two CBN officials, in collusion with unknown others, were demanding undue advantage from Ahmad.

According to the investigation agency, the inspectors allegedly threatened to implicate the nursing home owner in a fabricated case involving the procurement of a restricted drug unless he paid them a bribe.

The CBI launched a swift investigation and recovered Rs 10 lakh, which was reportedly paid by Ahmad to the accused officers. All three individuals — Singh, Ranjan, and Ahmad — were taken into custody following the recovery, the investigation agency said.

The agency has also named three private persons in the FIR, including Ahmad, and has left the scope open for further investigation into the involvement of unidentified individuals, a statement of the investigation agency has said.

Officials familiar with the probe said the arrests were made after corroborating the source-based intelligence with material evidence, including the recovered cash.

The CBI is now examining whether similar extortion tactics were employed in other cases and whether a broader network of corruption exists within the narcotics enforcement framework, it said.

The arrests have sparked concern over internal accountability mechanisms within the CBN, especially given its mandate to regulate controlled substances.

The CBI reiterated its commitment to rooting out corruption from enforcement agencies and emphasised that further inquiries are underway to identify additional suspects and determine the full extent of the conspiracy.

This case marks another chapter in the CBI’s ongoing efforts to uphold integrity in public service and ensure that regulatory powers are not misused for personal gain.

Related Posts

Piramal Pharma eyes mid-teens growth in FY27, prioritises organic expansion

Higher capacity utilisation, operating leverage and broad-based demand across CDMO, hospital generics and consumer healthcare are expected to support margins in FY27 Piramal Pharma expects to sustain mid-teen revenue growth…

IIT Bhubaneswar researchers develop portable device for accurate arsenic detection

Bhubaneswar: Researchers from the Sensors and Spectroscopy Research Group, School of Electrical and Computer Sciences (SECS), Indian Institute of Technology (IIT) Bhubaneswar, led by Dr. Sayan Dey, have made significant…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?